/PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced it will host an Investor Conference Call on Wednesday, January ...
Halozyme Therapeutics Competitors or Alternatives
Halozyme Therapeutics's top competitors include Amphastar Pharmaceuticals, Xenetic Biosciences and Ayala.
Halozyme Therapeutics VS Xenetic Biosciences
Xenetic Biosciences is one of Halozyme Therapeutics's top rivals. Xenetic Biosciences was founded in 2011, and its headquarters is in Framingham, Massachusetts. Like Halozyme Therapeutics, Xenetic Biosciences also works within the Biotechnology field. Xenetic Biosciences has 386 fewer employees than Halozyme Therapeutics.
Halozyme Therapeutics VS Ayala
Ayala is Halozyme Therapeutics's #3 rival. Ayala is a Public company that was founded in 2017 in Wilmington, Delaware. Like Halozyme Therapeutics, Ayala also competes in the Pharmaceuticals & Biotechnology sector. Compared to Halozyme Therapeutics, Ayala has 350 fewer employees.
Looking for similar companies to Halozyme Therapeutics?
Similar Companies
Companies in San Diego with revenue in $1.0-5.0B range
See 32 companies
Companies in San Diego with employees in 250-500 rangeSee 160 companies
Biotechnology companies with revenue in $1.0-5.0B rangeSee 60 companies
Companies in San Diego County with revenue in $1.0-5.0B rangeSee 42 companies
Pharmaceuticals & Biotechnology companies with revenue in $1.0-5.0B rangeSee 205 companies
Biotechnology companies with employees in 250-500 rangeSee 346 companies
Companies in San Diego County with employees in 250-500 rangeSee 507 companies
Companies in California with revenue in $1.0-5.0B rangeSee 533 companies
Biotechnology companies in San DiegoSee 556 companies
Trending News for Halozyme Therapeutics and Halozyme Therapeutics's Competitors
/CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2025 financial results after market close on Wednes...
Eight Phase II and Phase III clinical trials are under way across multiple tumour types, including melanoma, non-small cell lung cancer, bladder cancer...
INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ --......
Explore the exciting world of Halozyme Therapeutics (NASDAQ: HALO) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check ...
INDIANAPOLIS, Jan. 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2025 financial results on February 4, 20...
Renowned Urologist Serves on the Editorial Board of Authoritative Medical Reference MerckManuals.com
Provided as a public service by Merck & Co., Inc., access to MerckManuals.com is unlimited and always free, there is no registration, and visitors are ...
The companies have an expansive clinical program for the mRNA neoantigen therapy intismeran autogene in combination with immuno-oncology heavyweight Ke...
Frequently Asked Questions about Halozyme Therapeutics
Who are Halozyme Therapeutics's top competitors?
Halozyme Therapeutics's top 3 competitors are Amphastar Pharmaceuticals, Xenetic Biosciences, Ayala.Who is similar to Halozyme Therapeutics?
Amphastar Pharmaceuticals is the most similar to Halozyme Therapeutics. Xenetic Biosciences and Ayala are also similar to Halozyme Therapeutics.
Are Halozyme Therapeutics and Amphastar Pharmaceuticals competitors?
Yes, Amphastar Pharmaceuticals is one of Halozyme Therapeutics’s top competitors.